Tevogen Bio (G280.F) Q1 2026 Earnings

31MarConfirmed
Q1 2026
-1.3
-0.96
-0.63
-0.3

Details

Expected EPS
-1.2964499999999999
Actual EPS
N/A
Surprise EPS
1.3
Surprise Percent
+100%

Description

Tevogen Bio (G280.F) will report earnings of for Q1 2026 on March 31, 2026.

0 Comments

Share your thoughts